Dermata Therapeutics (DRMAW) Stock Chart & Stock Price History $0.01 0.00 (-19.70%) Closing price 09:29 AM EasternExtended Trading$0.01 0.00 (0.00%) As of 09:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Dermata Therapeutics Stock Price Performance 5 Day PerformanceN/A1 Month Performance-29.80%3 Month Performance-64.43%6 Month PerformanceN/AYear-To-Date Performance-0.93%1 Year Performance+10.42% Receive DRMAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address DRMAW Stock Chart for Thursday, May, 8, 2025 DRMAW Chart by TradingView Dermata Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2025$0.02$0.02+3.11%$0.03$0.0117,180 shs$0.0005/06/2025$0.02$0.02+0.52%$0.01$0.015,000 shs$0.0005/02/2025$0.02$0.02$0.01$0.015,000 shs$0.0005/01/2025$0.02$0.02-1.23%$0.01$0.015,000 shs$0.0004/30/2025$0.02$0.02$0.01$0.012,100 shs$0.0004/29/2025$0.01$0.02+24.62%$0.01$0.012,100 shs$0.0004/28/2025$0.01$0.01$0.02$0.0126,000 shs$0.0004/25/2025$0.02$0.01-35.00%$0.02$0.0126,000 shs$0.0004/24/2025$0.02$0.02-6.98%$0.02$0.021,400 shs$0.0004/23/2025$0.03$0.02-27.85%$0.03$0.026,800 shs$0.00 Get the Latest News and Ratings for DRMAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/22/2025$0.02$0.03+49.00%$0.03$0.031,500 shs$0.0004/21/2025$0.02$0.02-15.25%$0.02$0.02200 shs$0.0004/18/2025$0.02$0.02$0.02$0.02100 shs$0.0004/17/2025$0.02$0.02-3.67%$0.02$0.02100 shs$0.0004/16/2025$0.02$0.02+36.11%$0.03$0.0217,918 shs$0.0004/15/2025$0.02$0.02+2.86%$0.02$0.0211,445 shs$0.0004/14/2025$0.02$0.02+6.71%$0.02$0.02100 shs$0.0004/11/2025$0.02$0.02+8.61%$0.02$0.02101 shs$0.0004/10/2025$0.02$0.02$0.02$0.024,800 shs$0.0004/09/2025$0.02$0.02$0.02$0.024,894 shs$0.0004/09/2025$0.02$0.02$0.02$0.024,894 shs$0.0004/08/2025$0.02$0.02$0.02$0.022,600 shs$0.0004/08/2025$0.02$0.02$0.02$0.022,600 shs$0.0004/07/2025$0.02$0.02$0.02$0.022,600 shs$0.00 Related Companies ATNFW Stock Chart LBPSW Stock Chart AEHAW Stock Chart AIMDW Stock Chart ALVOW Stock Chart ACABW Stock Chart BFRIW Stock Chart BTMDW Stock Chart BCTXW Stock Chart CELUW Stock Chart Receive DRMAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DRMAW) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | SponsoredNew breed of trader (Wall Street hates us?)Wall Street big wigs and old-money bankers can’t touch this 1 type of stock. And that opens the door for tr...Timothy Sykes | Sponsored270x more lucrative than NVIDIA???270x more lucrative than NVIDIA??? If you've missed out on NVIDIA's recent 1,600% run... Don't worry. ...Behind the Markets | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredBITCOIN Liquidity pools are the backbone of crypto—and right now, they’re exploding with activity. By providing liqui...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dermata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DRMAW Stock Free DRMAW Stock Alerts